These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 37231285)

  • 1. A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment.
    Yang X; Zhang B
    Funct Integr Genomics; 2023 May; 23(2):182. PubMed ID: 37231285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratic journey of CRISPR/Cas9 in oncology from bench-work to successful-clinical therapy.
    Sarkar E; Khan A
    Cancer Treat Res Commun; 2021; 27():100289. PubMed ID: 33667951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
    Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas13 System as a Promising and Versatile Tool for Cancer Diagnosis, Therapy, and Research.
    Palaz F; Kalkan AK; Can Ö; Demir AN; Tozluyurt A; Özcan A; Ozsoz M
    ACS Synth Biol; 2021 Jun; 10(6):1245-1267. PubMed ID: 34037380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
    Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
    Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR: A Promising Tool for Cancer Therapy.
    Mohammad-Rafiei F; Safdarian E; Adel B; Vandchali NR; Navashenaq JG; Gheibihayat SM
    Curr Mol Med; 2023; 23(8):748-761. PubMed ID: 35748558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR Technology in Cancer Diagnosis and Treatment: Opportunities and Challenges.
    Shademan B; Masjedi S; Karamad V; Isazadeh A; Sogutlu F; Rad MHS; Nourazarian A
    Biochem Genet; 2022 Oct; 60(5):1446-1470. PubMed ID: 35092559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy.
    Wu HY; Cao CY
    Brief Funct Genomics; 2019 Mar; 18(2):129-132. PubMed ID: 29579146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy.
    Qin M; Deng C; Wen L; Luo G; Meng Y
    J Transl Med; 2024 May; 22(1):516. PubMed ID: 38816739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in CRISPR technologies for genome editing.
    Song M; Koo T
    Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current progress in CRISPR-Cas systems for cancer.
    Fatima H; Raja HA; Amir R; Gul A; Babar MM; Rajadas J
    Prog Mol Biol Transl Sci; 2024; 208():211-229. PubMed ID: 39266184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing the evolving CRISPR/Cas9 for precision oncology.
    Li T; Li S; Kang Y; Zhou J; Yi M
    J Transl Med; 2024 Aug; 22(1):749. PubMed ID: 39118151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research Progress on Nanoparticles-Based CRISPR/Cas9 System for Targeted Therapy of Tumors.
    Nie D; Guo T; Yue M; Li W; Zong X; Zhu Y; Huang J; Lin M
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer.
    Wang SW; Gao C; Zheng YM; Yi L; Lu JC; Huang XY; Cai JB; Zhang PF; Cui YH; Ke AW
    Mol Cancer; 2022 Feb; 21(1):57. PubMed ID: 35189910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas gene therapy.
    Zhang B
    J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology.
    Zhang D; Li Z; Li JF
    J Genet Genomics; 2016 May; 43(5):251-62. PubMed ID: 27165865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment.
    Mollanoori H; Shahraki H; Rahmati Y; Teimourian S
    Hum Immunol; 2018 Dec; 79(12):876-882. PubMed ID: 30261221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.